Lidocaine Hydrochloride Injection, Solution
FDA Label NDC 65282-1605

34 label sections · Submitted to the FDA by Spectra Medical Devices, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Spectra Medical Devices, Llc for the product Lidocaine Hydrochloride (NDC 65282-1605). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, description, mechanism of action:, hemodynamics:, pharmacokinetics and metabolism:, indication and usage:, contraindications:, warnings:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.